79 related articles for article (PubMed ID: 15566931)
1. Circulating tenascin-C levels in patients with idiopathic dilated cardiomyopathy.
Aso N; Tamura A; Nasu M
Am J Cardiol; 2004 Dec; 94(11):1468-70. PubMed ID: 15566931
[TBL] [Abstract][Full Text] [Related]
2. High prevalence of chronic myocarditis in dilated cardiomyopathy referred for left ventriculoplasty: expression of tenascin C as a possible marker for inflammation.
Tsukada B; Terasaki F; Shimomura H; Otsuka K; Otsuka K; Katashima T; Fujita S; Imanaka-Yoshida K; Yoshida T; Hiroe M; Kitaura Y
Hum Pathol; 2009 Jul; 40(7):1015-22. PubMed ID: 19297005
[TBL] [Abstract][Full Text] [Related]
3. Serum tenascin-C might be a novel predictor of left ventricular remodeling and prognosis after acute myocardial infarction.
Sato A; Aonuma K; Imanaka-Yoshida K; Yoshida T; Isobe M; Kawase D; Kinoshita N; Yazaki Y; Hiroe M
J Am Coll Cardiol; 2006 Jun; 47(11):2319-25. PubMed ID: 16750702
[TBL] [Abstract][Full Text] [Related]
4. Circulating tenascin-C levels in patients with dilated cardiomyopathy in the course of Emery-Dreifuss muscular dystrophy.
Niebroj-Dobosz I; Madej-Pilarczyk A; Marchel M; Sokołowska B; Hausmanowa-Petrusewicz I
Clin Chim Acta; 2011 Aug; 412(17-18):1533-8. PubMed ID: 21596026
[TBL] [Abstract][Full Text] [Related]
5. Higher serum tenascin-C levels reflect the severity of heart failure, left ventricular dysfunction and remodeling in patients with dilated cardiomyopathy.
Terasaki F; Okamoto H; Onishi K; Sato A; Shimomura H; Tsukada B; Imanaka-Yoshida K; Hiroe M; Yoshida T; Kitaura Y; Kitabatake A;
Circ J; 2007 Mar; 71(3):327-30. PubMed ID: 17322629
[TBL] [Abstract][Full Text] [Related]
6. [Impaired endothelium-dependent forearm vasodilation in idiopathic dilated cardiomyopathy is related to severe left ventricular dysfunction and elevated serum tumor necrosis factor levels].
Sitges M; Roig E; Morales M; Azqueta M; Pérez Villa F; Paré C; Orús J; Heras M; Sanz G
Rev Esp Cardiol; 2005 May; 58(5):477-83. PubMed ID: 15899192
[TBL] [Abstract][Full Text] [Related]
7. Reverse ventricular remodelling after cardiac resynchronization therapy is associated with a reduction in serum tenascin-C and plasma matrix metalloproteinase-9 levels.
Hessel MH; Bleeker GB; Bax JJ; Henneman MM; den Adel B; Klok M; Schalij MJ; Atsma DE; van der Laarse A
Eur J Heart Fail; 2007 Oct; 9(10):1058-63. PubMed ID: 17728181
[TBL] [Abstract][Full Text] [Related]
8. Clinical significance of troponin I efflux and troponin autoantibodies in patients with dilated cardiomyopathy.
Miettinen KH; Eriksson S; Magga J; Tuomainen P; Kuusisto J; Vanninen EJ; Turpeinen A; Punnonen KR; Pettersson K; Peuhkurinen KJ
J Card Fail; 2008 Aug; 14(6):481-8. PubMed ID: 18672196
[TBL] [Abstract][Full Text] [Related]
9. Relation between CD4+ T-cell activation and severity of chronic heart failure secondary to ischemic or idiopathic dilated cardiomyopathy.
Fukunaga T; Soejima H; Irie A; Sugamura K; Oe Y; Tanaka T; Nagayoshi Y; Kaikita K; Sugiyama S; Yoshimura M; Nishimura Y; Ogawa H
Am J Cardiol; 2007 Aug; 100(3):483-8. PubMed ID: 17659933
[TBL] [Abstract][Full Text] [Related]
10. Mineralocorticoid receptor antagonism ameliorates left ventricular diastolic dysfunction and myocardial fibrosis in mildly symptomatic patients with idiopathic dilated cardiomyopathy: a pilot study.
Izawa H; Murohara T; Nagata K; Isobe S; Asano H; Amano T; Ichihara S; Kato T; Ohshima S; Murase Y; Iino S; Obata K; Noda A; Okumura K; Yokota M
Circulation; 2005 Nov; 112(19):2940-5. PubMed ID: 16275882
[TBL] [Abstract][Full Text] [Related]
11. Changes in natriuretic peptides following passive containment surgery in heart failure patients with dilated cardiomyopathy.
Bredin F; Liska J; Franco-Cereceda A
Interact Cardiovasc Thorac Surg; 2009 Feb; 8(2):191-4. PubMed ID: 19008326
[TBL] [Abstract][Full Text] [Related]
12. Inflammatory markers and serum lipids in idiopathic dilated cardiomyopathy.
Sampietro T; Neglia D; Bionda A; Dal Pino B; Bigazzi F; Puntoni M; Startari U; Morales A; Minichilli F; Bianchi F; L'Abbate A
Am J Cardiol; 2005 Dec; 96(12):1718-20. PubMed ID: 16360363
[TBL] [Abstract][Full Text] [Related]
13. Utility of plasma apelin and other indices of cardiac dysfunction in the clinical assessment of patients with dilated cardiomyopathy.
Miettinen KH; Magga J; Vuolteenaho O; Vanninen EJ; Punnonen KR; Ylitalo K; Tuomainen P; Peuhkurinen KJ
Regul Pept; 2007 May; 140(3):178-84. PubMed ID: 17223209
[TBL] [Abstract][Full Text] [Related]
14. Cytokines, interstitial collagen and ventricular remodelling in dilated cardiomyopathy.
Timonen P; Magga J; Risteli J; Punnonen K; Vanninen E; Turpeinen A; Tuomainen P; Kuusisto J; Vuolteenaho O; Peuhkurinen K
Int J Cardiol; 2008 Mar; 124(3):293-300. PubMed ID: 17442428
[TBL] [Abstract][Full Text] [Related]
15. Reversed remodelling in dilated cardiomyopathy by passive containment surgery is associated with decreased circulating levels of endothelin-1.
Bredin F; Franco-Cereceda A
Eur J Cardiothorac Surg; 2006 Mar; 29(3):299-303. PubMed ID: 16442807
[TBL] [Abstract][Full Text] [Related]
16. Value of fibrosis markers for staging liver fibrosis in patients with precirrhotic alcoholic liver disease.
Lieber CS; Weiss DG; Paronetto F;
Alcohol Clin Exp Res; 2008 Jun; 32(6):1031-9. PubMed ID: 18422837
[TBL] [Abstract][Full Text] [Related]
17. Tenascin-C in human cardiac pathology.
Niebroj-Dobosz I
Clin Chim Acta; 2012 Oct; 413(19-20):1516-8. PubMed ID: 22687648
[TBL] [Abstract][Full Text] [Related]
18. Comparison of levels of matrix metalloproteinase-2 and -3 in patients with ischemic cardiomyopathy versus nonischemic cardiomyopathy.
Tziakas DN; Chalikias GK; Papaioakeim M; Hatzinikolaou EI; Stakos DA; Tentes IK; Papanas N; Kortsaris A; Maltezos E; Hatseras DI
Am J Cardiol; 2005 Nov; 96(10):1449-51. PubMed ID: 16275197
[TBL] [Abstract][Full Text] [Related]
19. Right ventricular function predicts transplant-free survival in idiopathic dilated cardiomyopathy.
La Vecchia L; Varotto L; Zanolla L; Spadaro GL; Fontanelli A
J Cardiovasc Med (Hagerstown); 2006 Sep; 7(9):706-10. PubMed ID: 16932086
[TBL] [Abstract][Full Text] [Related]
20. Serum matrix metalloproteinase-3 as a novel marker for risk stratification of patients with nonischemic dilated cardiomyopathy.
Ohtsuka T; Nishimura K; Kurata A; Ogimoto A; Okayama H; Higaki J
J Card Fail; 2007 Nov; 13(9):752-8. PubMed ID: 17996824
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
